Case Study: First-in-Human Trials Conducted in China
Case Study: First-in-Human Trials Conducted in China First-in-Human Trials in China: Regulatory Pathways and Case Insights Introduction First-in-Human (FIH) trials mark a critical milestone in clinical development, testing a new investigational product in humans for the first time. In China, the conduct of FIH trials has evolved significantly, reflecting regulatory reforms, site capacity building, and…
Read More “Case Study: First-in-Human Trials Conducted in China” »